Related Experiment Video
Updated: Apr 24, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Disseminated Bacillus Calmette-Guérin (BCG) Infection Presenting With a Miliary Pulmonary Pattern Following
Daniela Baptista1, Filipe Dias2, Sofia Sobral2
1Internal Medicine, Unidade Local de Saúde de Lisboa Ocidental, Lisbon, PRT.
Abstract:
Intravesical administration of Bacillus Calmette-Guérin (BCG) is a commonly employed therapeutic approach in clinical practice for the treatment of bladder neoplasms. Although it is generally safe, severe systemic complications may rarely arise. This report describes a patient with non-invasive papillary urothelial carcinoma treated with intravesical BCG therapy who developed disseminated infection with a miliary pattern. Although multiple attempts were made to isolate Mycobacterium bovis from blood, urine, and sputum samples, microbiological confirmation was never obtained. The diagnosis was therefore established presumptively based on the clinical presentation and epidemiological context, and anti-mycobacterial therapy was initiated accordingly. The patient's favorable clinical response to treatment further supported the diagnosis. This report describes a rare complication and a challenging diagnosis that should be considered in patients undergoing this form of treatment.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
07:14A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin
Published on: October 9, 2016
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Atypical Pneumonia